Thomas A. Lane, M.D.
Chief Medical Officer
Dr. Lane trained in Internal Medicine with subspecialties in Hematology and Transfusion Medicine, and then joined the faculty at UC San Diego School of Medicine in 1975, where he served as Chief of Transfusion Medicine from 1990 and Stem Cell Processing (2002) until joining PersImmune in 2015. He was instrumental in the development of PersImmune’s current clinical trials and Investigational New Drug (IND) applications and remains an Emeritus Professor of Pathology at UCSD School of Medicine. Dr. Lane’s career as a clinician, teacher, and researcher included extensive experience and leadership positions in academic medicine, laboratory investigation, service to professional societies, and clinical trials, the latter including cellular therapy and most recently adoptive immunotherapy. His bibliography includes more than 100 peer-reviewed publications and numerous research presentations at national societies.